Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02739035 · ClinicalTrials.gov registry record · Phase 4
MUA to Treat Postoperative Stiffness After Total Knee Arthroplasty
A Phase 4 study of Stiffness Following Total Knee Arthroplasty, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 130
- Enrollment target
- 16
- Study locations
NCT02739035 is a Phase 4 study of Stiffness Following Total Knee Arthroplasty that has completed, run by Mayo Clinic. The registered enrollment target is 130 participants. The trial reports 16 study locations across 11 states.
The verdict
NCT02739035, a Phase 4 study of Stiffness Following Total Knee Arthroplasty, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 130 participants
- Enrollment target
- 16
- Study locations
Study Summary
Compare the outcome following manipulation under anesthesia for stiffness in a randomized controlled fashion with one group receiving IV dexamethasone and oral celecoxib at the time of manipulation to a control group receiving manipulation alone. Outcomes will include pain, range of motion, as well as subjective outcome scores.
Conditions Studied
Interventions
- DRUG Dexamethasone
- DRUG Celecoxib
Study Locations (16)
New York
- Hospital for Joint Diseases - New York
- Hospital for Special Surgery - New York
- New York - Presbyterian at Columbia University - New York
North Carolina
- OrthoCarolina - Charlotte
- Duke University Medical Ceter, Dept. of Orthopaedics - Durham
Ohio
- Cleveland Clinic - Cleveland
- Joint Implant Surgeons - New Albany
Pennsylvania
- Rothman Institute - Lansdale
- Aria 3B Orthopaedic Specialists - Philadelphia
Arkansas
- HipKnee Arkansas Foundation - Little Rock
Colorado
- Colorado Joint Replacement - Denver
Illinois
- Rush University Medical Center - Chicago
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2016-04 |
| Est. Completion | 2022-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02739035
The ClinicalTrials.gov registry entry for NCT02739035 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stiffness Following Total Knee Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Dexamethasone is the first listed.
NCT02739035 reports 16 study locations spanning 11 distinct geographic areas - top geographies include New York, North Carolina, Ohio.
Frequently Asked Questions
What is clinical trial NCT02739035 about?
NCT02739035 is a clinical study titled "MUA to Treat Postoperative Stiffness After Total Knee Arthroplasty". Compare the outcome following manipulation under anesthesia for stiffness in a randomized controlled fashion with one group receiving IV dexamethasone and oral celecoxib at the time of manipulation to a control group receiving manipulation alone. Outcomes will include pain, range of motion, as well...
What is the current status of trial NCT02739035?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 130 participants. The study started on 2016-04. Estimated completion is 2022-12.
What conditions does trial NCT02739035 study?
This clinical trial studies the following conditions: Stiffness Following Total Knee Arthroplasty.
What interventions are being tested in trial NCT02739035?
The interventions under investigation include: Dexamethasone (DRUG), Celecoxib (DRUG).
Who is sponsoring clinical trial NCT02739035?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02739035 being conducted?
This trial has 16 study locations across Arkansas, Colorado, Illinois, Minnesota, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.